Intensity modulated radiotherapy for stage III non-small cell lung cancer in the United States: predictors of use and association with toxicities.
about
Considerations for observational research using large data sets in radiation oncologyNovel radiotherapy approaches for lung cancer: combining radiation therapy with targeted and immunotherapiesThe radiation techniques of tomotherapy & intensity-modulated radiation therapy applied to lung cancerIntensity-modulated radiotherapy, not 3 dimensional conformal, is the preferred technique for treating locally advanced lung cancerRadiotherapy Techniques and Radiation Pneumonitis: A Lot To A Little Or A Little To A Lot?A critical review of recent developments in radiotherapy for non-small cell lung cancerThe Role of Surgical Resection in Stage IIIA Non-Small Cell Lung Cancer: A Decision and Cost-Effectiveness Analysis.Esophagus and Contralateral Lung-Sparing IMRT for Locally Advanced Lung Cancer in the Community Hospital Setting.Is IMRT Superior or Inferior to 3DCRT in Radiotherapy for NSCLC? A Meta-Analysis.Dose distribution and tumor control probability in out-of-field lymph node stations in intensity modulated radiotherapy (IMRT) vs 3D-conformal radiotherapy (3D-CRT) of non-small-cell lung cancer: an in silico analysis.Analysis of Clinical and Dosimetric Factors Influencing Radiation-Induced Lung Injury in Patients with Lung Cancer.Comparison of Toxicity Between Intensity-Modulated Radiotherapy and 3-Dimensional Conformal Radiotherapy for Locally Advanced Non-small-cell Lung CancerEffect of Radiation Therapy Techniques on Outcome in N3-positive IIIB Non-small Cell Lung Cancer Treated with Concurrent ChemoradiotherapyImpact of Intensity-Modulated Radiation Therapy Technique for Locally Advanced Non-Small-Cell Lung Cancer: A Secondary Analysis of the NRG Oncology RTOG 0617 Randomized Clinical Trial.Role of interim 18F-FDG-PET/CT for the early prediction of clinical outcomes of Non-Small Cell Lung Cancer (NSCLC) during radiotherapy or chemo-radiotherapy. A systematic review.Cost of Intensity-modulated Radiation Therapy for Older Patients with Stage III Lung CancerComparison of survival rates between 3D conformal radiotherapy and intensity-modulated radiotherapy in patients with stage III non-small cell lung cancer.Radiotherapy Dosing for Locally Advanced Non-Small Cell Lung Carcinoma: "MTD" or "ALARA"?Prediction of Radiation Esophagitis in Non-Small Cell Lung Cancer Using Clinical Factors, Dosimetric Parameters, and Pretreatment Cytokine Levels.Guidelines for the treatment of lung cancer using radiotherapy.Reducing dose to the lungs through loosing target dose homogeneity requirement for radiotherapy of non small cell lung cancer.IMRT and 3D conformal radiotherapy with or without elective nodal irradiation in locally advanced NSCLC: A direct comparison of PET-based treatment planning.Advanced radiation techniques for locally advanced non-small cell lung cancer: intensity-modulated radiation therapy and proton therapy
P2860
Q24289442-C1FF3005-2BA6-467A-9DE3-1FA0F74BF981Q26775388-686DD444-48C4-458C-BF81-8659CE903C8FQ26799892-C77B627A-2719-4508-9224-29E44E7BF887Q26851310-9CE4B2C3-2428-4A83-A621-FEE1F4DBC78FQ28068005-C0BFDF2D-9045-42AC-982F-65A59D160F2DQ28079625-6C667DED-4B57-4FE8-AACA-8F69CFC6B0DEQ30749009-40D3C7F2-0608-4897-9BA9-26825086ACA4Q35768924-7F54E402-E0E2-4D4E-A639-5A777C541FFCQ35996078-7DAC3EF9-5135-4B1B-BC26-6084872B8CC6Q36010155-BFF5CF93-C72E-4957-94F6-93C31C91471DQ36190155-8303F74A-84E6-4578-A4B6-F33B3F907520Q36447645-1ECE564C-5491-4E18-84DE-5CAEB8AAA0A3Q36482508-3B40D6D1-7628-462F-8C71-D75DFEEDA302Q39052564-BF79A09A-3D54-4A1E-8628-8E869E8BEF24Q39417217-64CAE919-BC17-4FC5-A1F2-8A8663E8C37CQ40702169-2F9F84CE-5906-43E7-A0A7-FF192E236B5EQ42362650-09B31D71-9AAC-4132-8819-38082B72EE18Q42363788-6FD69B06-C25B-4CA7-80EC-240DE5EDE53EQ47342475-B176214A-5F58-4226-ACB0-EBE9A4A2C180Q49849023-AD307DFA-B88C-4942-A601-53AA4066939FQ50099060-308C2B5E-3A6F-4771-9593-9B296EE05670Q52990447-3F6F709A-01CC-4274-9152-C9B1173C0195Q57172945-8F37E43D-D3F6-43E6-BB4C-B57AC59914B8
P2860
Intensity modulated radiotherapy for stage III non-small cell lung cancer in the United States: predictors of use and association with toxicities.
description
2013 nî lūn-bûn
@nan
2013 թուականի Օգոստոսին հրատարակուած գիտական յօդուած
@hyw
2013 թվականի օգոստոսին հրատարակված գիտական հոդված
@hy
2013年の論文
@ja
2013年論文
@yue
2013年論文
@zh-hant
2013年論文
@zh-hk
2013年論文
@zh-mo
2013年論文
@zh-tw
2013年论文
@wuu
name
Intensity modulated radiothera ...... d association with toxicities.
@ast
Intensity modulated radiothera ...... d association with toxicities.
@en
type
label
Intensity modulated radiothera ...... d association with toxicities.
@ast
Intensity modulated radiothera ...... d association with toxicities.
@en
prefLabel
Intensity modulated radiothera ...... d association with toxicities.
@ast
Intensity modulated radiothera ...... d association with toxicities.
@en
P2093
P2860
P1433
P1476
Intensity modulated radiothera ...... d association with toxicities.
@en
P2093
Daniel R Gomez
Jing Jiang
Joe Y Chang
Shervin M Shirvani
Thomas A Buchholz
P2860
P304
P356
10.1016/J.LUNGCAN.2013.08.015
P577
2013-08-21T00:00:00Z